[HTML][HTML] Pre-eclampsia
Pre-eclampsia is a life-threatening disease of pregnancy unique to humans and a leading
cause of maternal and neonatal morbidity and mortality. Women who survive pre-eclampsia …
cause of maternal and neonatal morbidity and mortality. Women who survive pre-eclampsia …
Preeclampsia
LA Magee, KH Nicolaides… - New England Journal of …, 2022 - Mass Medical Soc
Preeclampsia Preeclampsia complicates 2 to 4% of all pregnancies and accounts for about
46,000 maternal deaths and 500,000 fetal or newborn deaths each year. Antihypertensive …
46,000 maternal deaths and 500,000 fetal or newborn deaths each year. Antihypertensive …
Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic …
OBJECTIVE: To determine whether the use of vaginal progesterone in asymptomatic women
with a sonographic short cervix (≤ 25 mm) in the midtrimester reduces the risk of preterm …
with a sonographic short cervix (≤ 25 mm) in the midtrimester reduces the risk of preterm …
[HTML][HTML] Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia
Background Preterm preeclampsia is an important cause of maternal and perinatal death
and complications. It is uncertain whether the intake of low-dose aspirin during pregnancy …
and complications. It is uncertain whether the intake of low-dose aspirin during pregnancy …
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation
RJM Snijders, P Noble, N Sebire, A Souka… - The Lancet, 1998 - thelancet.com
Background Prenatal diagnosis of trisomy 21 currently relies on assessment of risk followed
by invasive testing in the 5% of pregnancies at the highest estimated risk. Selection of the …
by invasive testing in the 5% of pregnancies at the highest estimated risk. Selection of the …
Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
KH Nicolaides, G Azar, D Byrne, C Mansur… - British medical …, 1992 - bmj.com
OBJECTIVE--To examine the significance of fetal nuchal translucency at 10-14 weeks'
gestation in the prediction of abnormal fetal karyotype. DESIGN--Prospective screening …
gestation in the prediction of abnormal fetal karyotype. DESIGN--Prospective screening …
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study
Objectives To validate the clinical efficacy and practical feasibility of massively parallel
maternal plasma DNA sequencing to screen for fetal trisomy 21 among high risk …
maternal plasma DNA sequencing to screen for fetal trisomy 21 among high risk …
Progesterone and the risk of preterm birth among women with a short cervix
Although progesterone given prophylactically to women with a history of preterm birth cuts
the recurrence rate in half, only about 10% of spontaneous early preterm births take place in …
the recurrence rate in half, only about 10% of spontaneous early preterm births take place in …
A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated …
K Spencer, V Souter, N Tul, R Snijders… - … in Obstetrics and …, 1999 - Wiley Online Library
Objective To examine the potential impact of combining maternal age with fetal nuchal
translucency thickness and maternal serum free β‐human chorionic gonadotropin (β‐hCG) …
translucency thickness and maternal serum free β‐human chorionic gonadotropin (β‐hCG) …
[HTML][HTML] The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and …
LC Poon, A Shennan, JA Hyett, A Kapur… - … of gynaecology and …, 2019 - ncbi.nlm.nih.gov
Preeclampsia (PE) is a multisystem disorder that typically affects 2%− 5% of pregnant
women and is one of the leading causes of maternal and perinatal morbidity and mortality …
women and is one of the leading causes of maternal and perinatal morbidity and mortality …